Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Carcinoma
×
Everolimus
×
Clear all
Filters
3
NCT01035229
2016-09-22
EVOLVE-1
Novartis
Phase 3
Completed
546 enrolled
18 charts
NCT00412061
2014-11-21
RADIANT-2
Novartis
Phase 3
Completed
429 enrolled
13 charts